Multi-stage delivery nano-particle systems for therapeutic applications
about
Multifunctional iron platinum stealth immunomicelles: targeted detection of human prostate cancer cells using both fluorescence and magnetic resonance imagingNanomedicine concepts in the general medical curriculum: initiating a discussionConvergence of nanotechnology and cancer prevention: are we there yet?Biocompatibility assessment of Si-based nano- and micro-particlesPeripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in miceSilicon particles as trojan horses for potential cancer therapy.Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors.Characterization of Free and Porous Silicon-Encapsulated Superparamagnetic Iron Oxide Nanoparticles as Platforms for the Development of Theranostic Vaccines.Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections.Cancer cell invasion: treatment and monitoring opportunities in nanomedicine.Redirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver MetastasesDownregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulationIndoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapyBiotargeted nanomedicines for cancer: six tenets before you beginPreparation, characterization, and cellular associations of silicon logic-embedded vectorsMultistage nanoparticles for improved delivery into tumor tissuePorous silicon advances in drug delivery and immunotherapy.Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance.Biomolecule delivery to engineer the cellular microenvironment for regenerative medicine.Nanomedicine: application areas and development prospects.Particle platforms for cancer immunotherapy.Recent advances in porous silicon technology for drug delivery.Non-Viral Delivery and Therapeutic Application of Small Interfering RNAs.Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications.Nanotechnology applications in diagnosis and treatment of metastasis.Mathematical modeling analysis of intratumoral disposition of anticancer agents and drug delivery systems.Porous silicon for drug delivery applications and theranostics: recent advances, critical review and perspectives.The Emerging Role of Nanotechnology in Cell and Organ Transplantation.Two-Dimensional Nanomaterials for Biomedical Applications: Emerging Trends and Future Prospects.Silica nanoparticles induce cardiotoxicity interfering with energetic status and Ca2+ handling in adult rat cardiomyocytes.Polymeric microspheres as protein transduction reagents.Bottom-Up Instructive Quality Control in the Biofabrication of Smart Protein Materials.Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnology.Enhanced gene delivery in porcine vasculature tissue following incorporation of adeno-associated virus nanoparticles into porous silicon microparticles.Thrombin generation assay and transmission electron microscopy: a useful combination to study tissue factor-bearing microvesicles.Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium.Low pressure mediated enhancement of nanoparticle and macromolecule loading into porous silicon structures.A functional nanocarrier that copenetrates extracellular matrix and multiple layers of tumor cells for sequential and deep tumor autophagy inhibitor and chemotherapeutic delivery.Chitosan supraparticles with fluorescent silica nanoparticle shells and nanodiamond-loaded cores
P2860
Q24634139-684783B4-A3CE-4BBA-AF7C-10655B471C34Q26775137-1A8EFCBD-C126-4756-89AC-26CBC92C2BECQ28386699-29FC73AC-AEBF-47FE-8CB9-006538DF416EQ28389467-04B7C4A8-B0BC-46F1-A8DF-67963C57C7F4Q28486624-095920BC-61D3-4D43-A419-F01AA83BB9C4Q30412166-19C75031-5C75-4549-A82E-D9BA9D53A632Q30425859-90E0A023-DCAF-422A-B854-506554773589Q33752929-4914405C-92CD-476C-9312-F38B21F6C5FCQ33935474-04FC7A5B-6F1D-46C4-8A3F-2CEC029591EFQ35093966-4503D1E5-D215-4513-88F2-7B49BE78D65DQ36471409-0797C1A4-15AA-49D8-AEA6-97D4E33670B0Q36642844-CBA8F0EB-73C1-4C0D-BA6E-02208A42BC59Q36646476-F70E4FB5-D23C-4C7B-94BB-00807096F891Q36814280-67E2AC10-3021-4550-906D-145707047F73Q37148412-1561E9CA-1A75-478C-9E46-4C6DB5457FD5Q37176313-CE3F82E2-6F1C-41B6-B2EB-1C6E9F7638F6Q37227659-A7156DD8-F592-456F-AF61-9FA09B4C1A94Q37302933-B6B18EA0-CF32-466C-B5AD-741590F6ABA7Q37561973-28EC7633-3579-49F6-8955-D2BFCF477660Q37735550-519A2D6A-CCDD-4263-901D-4F8018249736Q37891690-FAB8D48D-E265-4D2C-AE10-5301BB7A9488Q38114060-0D350C94-5B27-491D-8DB8-75D2A831F31AQ38123855-B87BCE78-2996-408C-B819-E287AF48960AQ38168518-9E0DDFF5-889C-4AB9-BBE8-5B3E95DCBFC1Q38208617-1F918FA1-E0DB-4CFA-B054-C77768335163Q38254086-C31851F1-06D2-499B-8F1F-F02BE134C13DQ38392523-56D9851E-CF42-45A4-9074-DCCCA6B958A7Q38732021-46066BBA-C4F6-4D96-81A7-1E077EF5FB56Q38852662-4CC2E301-20FA-483F-8F72-55279F542AC4Q38954326-DCCA59E0-8CE0-4091-B05F-42C7A0ECCEBEQ38994567-1DB8A111-66AA-4286-A055-8C8E311491A9Q40373344-ADE36FF9-2983-4968-BF62-FA730A21FDBEQ40384339-DB843DA1-DC85-46BD-8BAE-25B534977C14Q42145728-4AFBC4B5-B1D8-4512-A4F5-57EE6B49DDA0Q42194547-661C990E-F2F6-4B24-AFF6-9FD3FECE7ECAQ42248974-B043C40A-C0BD-4EAB-A4C1-EDE94ED89415Q42380474-8787EDC0-7176-4251-A711-1D6CF85D0DEFQ43054291-F06B4E1D-1802-4637-9055-9DF867CCBB13Q46129533-BAFCDE4A-5712-47C3-A6FC-1F4A3388D387Q57367594-1FCEA78E-A722-4BCC-9470-6FC5BDED2508
P2860
Multi-stage delivery nano-particle systems for therapeutic applications
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Multi-stage delivery nano-particle systems for therapeutic applications
@ast
Multi-stage delivery nano-particle systems for therapeutic applications
@en
Multi-stage delivery nano-particle systems for therapeutic applications
@nl
type
label
Multi-stage delivery nano-particle systems for therapeutic applications
@ast
Multi-stage delivery nano-particle systems for therapeutic applications
@en
Multi-stage delivery nano-particle systems for therapeutic applications
@nl
prefLabel
Multi-stage delivery nano-particle systems for therapeutic applications
@ast
Multi-stage delivery nano-particle systems for therapeutic applications
@en
Multi-stage delivery nano-particle systems for therapeutic applications
@nl
P2093
P2860
P1476
Multi-stage delivery nano-particle systems for therapeutic applications
@en
P2093
Biana Godin
Ciro Chiappini
Mauro Ferrari
Rita E Serda
P2860
P304
P356
10.1016/J.BBAGEN.2010.05.004
P407
P50
P577
2010-05-21T00:00:00Z